Arcus Biosciences (RCUS) Free Cash Flow Growth (3y) (2020 - 2026)
Arcus Biosciences (RCUS) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
20.11% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arcus Biosciences |
3.05 Bn |
2.23 Bn |
- |
-10.96% |
| Date | Value |
|---|
| Mar 31, 2026 |
-10.96% |
| Dec 31, 2025 |
-19.35% |
| Sep 30, 2025 |
-5.33% |
| Jun 30, 2025 |
-25.06% |
| Mar 31, 2025 |
-30.13% |
| Dec 31, 2024 |
-30.58% |
| Sep 30, 2024 |
33.62% |
| Jun 30, 2024 |
-7.68% |
| Mar 31, 2024 |
64.85% |
| Dec 31, 2023 |
-10.89% |
| Sep 30, 2023 |
-32.72% |
| Jun 30, 2023 |
-37.52% |
| Mar 31, 2023 |
-47.48% |
| Dec 31, 2022 |
-94.93% |
| Sep 30, 2022 |
-46.77% |
| Jun 30, 2022 |
-49.01% |
| Mar 31, 2022 |
241.78% |
| Dec 31, 2021 |
-61.61% |
| Sep 30, 2021 |
-81.41% |
| Jun 30, 2021 |
-90.78% |
